piR-39980 mediates doxorubicin resistance in fibrosarcoma by regulating drug accumulation and DNA repair
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
piR-39980 mediates doxorubicin resistance in fibrosarcoma by regulating drug accumulation and DNA repair
Authors
Keywords
-
Journal
Communications Biology
Volume 4, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-11-19
DOI
10.1038/s42003-021-02844-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- piRNAs: biogenesis and their potential roles in cancer
- (2020) Binghong Guo et al. CANCER AND METASTASIS REVIEWS
- Mechanisms of Multidrug Resistance in Cancer Chemotherapy
- (2020) Karol Bukowski et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- miRNA‐765 mediates multidrug resistance via targeting BATF2 in gastric cancer cells
- (2020) Wan Lin et al. FEBS Open Bio
- Inhibiting RRM2 to enhance the anticancer activity of chemotherapy
- (2020) Yaqiong Zhan et al. BIOMEDICINE & PHARMACOTHERAPY
- Co-expression Network Analysis Identifies Four Hub Genes Associated With Prognosis in Soft Tissue Sarcoma
- (2019) Zhenhua Zhu et al. Frontiers in Genetics
- MiR-20a-5p regulates gemcitabine chemosensitivity by targeting RRM2 in pancreatic cancer cells and serves as a predictor for gemcitabine based chemotherapy
- (2019) Huimin Lu et al. BIOSCIENCE REPORTS
- A Novel Mechanism Driving Poor-Prognosis Prostate Cancer: Overexpression of the DNA Repair Gene, Ribonucleotide Reductase Small Subunit M2 (RRM2)
- (2019) Ying Z. Mazzu et al. CLINICAL CANCER RESEARCH
- Drug metabolizing enzymes-associated chemo resistance and strategies to overcome it
- (2019) Himanshu Verma et al. DRUG METABOLISM REVIEWS
- Noncoding RNAs in cancer therapy resistance and targeted drug development
- (2019) Wen-Tao Wang et al. Journal of Hematology & Oncology
- PIWI‐interacting RNA 39980 promotes tumor progression and reduces drug sensitivity in neuroblastoma cells
- (2019) Jyoti Roy et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Emerging roles of piRNAs in cancer: challenges and prospects
- (2019) Ye Cheng et al. Aging-US
- piR‐39980 promotes cell proliferation, migration and invasion, and inhibits apoptosis via repression of SERPINB1 in human osteosarcoma
- (2019) Basudeb Das et al. BIOLOGY OF THE CELL
- Discovery of Novel Doxorubicin Metabolites in MCF7 Doxorubicin-Resistant Cells
- (2019) Xu Wang et al. Frontiers in Pharmacology
- Novel evidence for a PIWI-interacting RNA (piRNA) as an oncogenic mediator of disease progression, and a potential prognostic biomarker in colorectal cancer
- (2018) Wenhao Weng et al. Molecular Cancer
- siRNA Knockdown of RRM2 Effectively Suppressed Pancreatic Tumor Growth Alone or Synergistically with Doxorubicin
- (2018) Shuquan Zheng et al. Molecular Therapy-Nucleic Acids
- Tumor suppressive activity of PIWI-interacting RNA in human fibrosarcoma mediated through repression of RRM2
- (2018) Basudeb Das et al. MOLECULAR CARCINOGENESIS
- MicroRNA-377 suppresses initiation and progression of esophageal cancer by inhibiting CD133 and VEGF
- (2017) B Li et al. ONCOGENE
- The emergence of piRNAs against transposon invasion to preserve mammalian genome integrity
- (2017) Christina Ernst et al. Nature Communications
- Identification and characterization of RASSF1C piRNA target genes in lung cancer cells
- (2017) Mark E. Reeves et al. Oncotarget
- Noncoding RNA in drug resistant sarcoma
- (2017) Xiaoyang Li et al. Oncotarget
- Regulation of multidrug resistance by microRNAs in anti-cancer therapy
- (2017) Xin An et al. Acta Pharmaceutica Sinica B
- Chemotherapy for soft tissue sarcoma
- (2016) Ravin Ratan et al. CANCER
- piR-651 promotes tumor formation in non-small cell lung carcinoma through the upregulation of cyclin D1 and CDK4
- (2016) Dan Li et al. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- Soft tissue sarcoma of the extremities: pending questions on surgery and radiotherapy
- (2016) Fien Hoefkens et al. Radiation Oncology
- PiwiRNA-651 as marker of treatment response and survival in classical Hodgkin lymphoma
- (2016) Anna Cordeiro et al. Oncotarget
- Stem-Loop RT-qPCR as an Efficient Tool for the Detection and Quantification of Small RNAs in Giardia lamblia
- (2016) Jaime Marcial-Quino et al. Genes
- Doxorubicin alone versus intensified doxorubicin plus ifosfamide for first-line treatment of advanced or metastatic soft-tissue sarcoma: a randomised controlled phase 3 trial
- (2014) Ian Judson et al. LANCET ONCOLOGY
- piRNA-823 contributes to tumorigenesis by regulating de novo DNA methylation and angiogenesis in multiple myeloma
- (2014) H Yan et al. LEUKEMIA
- OpenComet: An automated tool for comet assay image analysis
- (2014) Benjamin M. Gyori et al. Redox Biology
- Reduced Intracellular Drug Accumulation in Drug-Resistant Leukemia Cells is Not Only Solely Due to MDR-Mediated Efflux but also to Decreased Uptake
- (2014) Angela Oliveira Pisco et al. Frontiers in Oncology
- Molecular mechanisms of radiation resistance in doxorubicin-resistant breast adenocarcinoma cells
- (2013) LIDIA LUZHNA et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Bleach gel: A simple agarose gel for analyzing RNA quality
- (2012) Patrick S. Aranda et al. ELECTROPHORESIS
- Gene expression alterations in doxorubicin resistant MCF7 breast cancer cell line
- (2012) Shatha AbuHammad et al. GENOMICS
- Doxorubicin: an update on anticancer molecular action, toxicity and novel drug delivery systems
- (2012) Oktay Tacar et al. JOURNAL OF PHARMACY AND PHARMACOLOGY
- Increased Expression of P-Glycoprotein Is Associated with Doxorubicin Chemoresistance in the Metastatic 4T1 Breast Cancer Model
- (2011) Lili Bao et al. AMERICAN JOURNAL OF PATHOLOGY
- piR-823, a novel non-coding small RNA, demonstrates in vitro and in vivo tumor suppressive activity in human gastric cancer cells
- (2011) Jia Cheng et al. CANCER LETTERS
- Activation of the aryl hydrocarbon receptor by doxorubicin mediates cytoprotective effects in the heart
- (2011) Maria Volkova et al. CARDIOVASCULAR RESEARCH
- piRNA, the new non-coding RNA, is aberrantly expressed in human cancer cells
- (2011) Jia Cheng et al. CLINICA CHIMICA ACTA
- γH2AX: a sensitive molecular marker of DNA damage and repair
- (2010) L-J Mah et al. LEUKEMIA
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search